Evidence map›Paper›PMID 35971057›Full record

Observational studyBMC medical research methodology2022

Measuring and controlling medical record abstraction (MRA) error rates in an observational study.

Maryam Y Garza, Tremaine Williams, Sahiti Myneni, Susan H Fenton, Songthip Ounpraseuth, Zhuopei Hu, Jeannette Lee, Jessica Snowden, Meredith N Zozus, Anita C Walden and 9 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC medical research methodology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Uncertainties in outcome modelling in radiation oncology.Physics and imaging in radiation oncology · 2025
    Review
  12. Article
  13. Observational
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 12 institutions in 1 country.

Maryam Y GarzaDepartment of Biomedical Informatics, University of Arkansas for Medical Sciences, 4301 W Markham St., #782, Little Rock, AR, 72205, USA. mygarza@uams.edu.
Tremaine WilliamsDepartment of Biomedical Informatics, University of Arkansas for Medical Sciences, 4301 W Markham St., #782, Little Rock, AR, 72205, USA.
Sahiti MyneniSchool of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, USA.
Susan H FentonSchool of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, USA.
Songthip OunpraseuthDepartment of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Zhuopei HuDepartment of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Jeannette LeeDepartment of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Jessica SnowdenDepartment of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Meredith N ZozusUniversity of Texas Health Science Center at San Antonio, Joe R. & Teresa Lozano Long School of Medicine, San Antonio, TX, USA.
Anita C WaldenDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, OR, USA.
Alan E SimonEnvironmental Influences On Child Health Outcomes (ECHO) Program, National Institutes of Health, Rockville, MD, USA.
Barbara McClaskeyPittsburg State University, Pittsburg, KS, USA.
Sarah G SandersDepartment of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Sandra S BeaumanDepartment of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Sara R FordDepartment of Pediatrics, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Lacy MallochUniversity of Mississippi Medical Center, Jackson, MS, USA.
Amy WilsonAlaska Native Tribal Health Consortium, Anchorage, Alaska, USA.
Lori A DevlinDepartment of Pediatrics, University of Louisville, Louisville, KY, USA.
Leslie W YoungDepartment of Pediatrics, The Larner College of Medicine at the University of Vermont, Burlington, VT, USA.
University of Arkansas for Medical Sciences · USThe University of Texas Health Science Center at Houston · USUniversity of New Mexico · USAlaska Native Tribal Health Consortium · USBrown University · USNational Institutes of Health · USOregon Health & Science University · USPittsburg State University · USThe University of Texas Health Science Center at San Antonio · USUniversity of Louisville · USUniversity of Mississippi Medical Center · USUniversity of Vermont · US

Funding

Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials NetworkU24OD024957 · OD · UNIV OF ARKANSAS FOR MED SCIS · PI COURTNEY, SHERRY, OUNPRASEUTH, SONGTHIP T. · 2016 to 2024
$80.8M
Expanding Translational Research in ArkansasUL1TR003107 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI JAMES, LAURA P · 2019 to 2023
$21.6M
IMproving Pediatric Access to Clinical Trials in Vermont (IMPACT VT)UG1OD024955 · OD · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Kelly Jean Cowan, Leslie W Young · 2016 to 2026
$4.8M
MS-ISPCTN (Cycle 3)UG1OD024942 · OD · UNIVERSITY OF MISSISSIPPI MED CTR · PI Joseph Marc Majure · 2016 to 2026
$4.7M
Sunflower Pediatric Clinical Trials (SPeCTr 3.0)UG1OD024943 · OD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Ann M Davis, BRIDGETTE L. JONES · 2016 to 2026
$4.7M
Rhode Island Child Clinical Trials CollaborativeUG1OD024951 · OD · RHODE ISLAND HOSPITAL · PI THOMAS H CHUN, PHYLLIS A. DENNERY · 2016 to 2026
$4.7M
UNM Pediatric Clinical Trial Sites in IDeA State Pediatric Clinical Trial NetworkUG1OD024947 · OD · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Jessie R. Maxwell, Hengameh H Raissy · 2016 to 2026
$4.6M
ISPCTN Pediatric Clinical Trials UnitUG1OD024946 · OD · DARTMOUTH-HITCHCOCK CLINIC · PI Tyler Hartman, Paul E. Palumbo · 2016 to 2026
$4.6M
The Kentucky Pediatric Clinical Trials Rural/Urban PartnershipUG1OD024954 · OD · UNIVERSITY OF LOUISVILLE · PI Lori Ann Devlin-Phinney, Sara E Watson · 2016 to 2026
$4.3M
Louisiana Pediatric Clinical Trials NetworkUG1OD024959 · OD · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI John C Carlson, Amanda E. Staiano · 2016 to 2026
$4.1M
West Virginia Pediatric Clinical Trials Network - 3UG1OD030016 · OD · WEST VIRGINIA UNIVERSITY · PI MARGARET JAYNES, LEE A PYLES · 2020 to 2026
$2.9M
Evaluation of a HEPA Filter Pilot Project: Formative Data to Support a Future Indoor Air Quality Bronchiolitis Clinical TrialUG1OD024944 · OD · ALASKA NATIVE TRIBAL HEALTH CONSORTIUM · PI HIRSCHFELD, MATTHEW J, KECK, JAMES W. · 2016 to 2024
$2.3M
NCATS NIH HHS UL1 TR003107NIH HHS U24 OD024957NIH HHS UG1 OD024942NIH HHS UG1 OD024943NIH HHS UG1 OD024944NIH HHS UG1 OD024946NIH HHS UG1 OD024947NIH HHS UG1 OD024951NIH HHS UG1 OD024954NIH HHS UG1 OD024955NIH HHS UG1 OD024959NIH HHS UG1 OD030016
6 · The paper itself

Abstract

backgroundStudies have shown that data collection by medical record abstraction (MRA) is a significant source of error in clinical research studies relying on secondary use data. Yet, the quality of data collected using MRA is seldom assessed. We employed a novel, theory-based framework for data quality assurance and quality control of MRA. The objective of this work is to determine the potential impact of formalized MRA training and continuous quality control (QC) processes on data quality over time.

methodsWe conducted a retrospective analysis of QC data collected during a cross-sectional medical record review of mother-infant dyads with Neonatal Opioid Withdrawal Syndrome. A confidence interval approach was used to calculate crude (Wald's method) and adjusted (generalized estimating equation) error rates over time. We calculated error rates using the number of errors divided by total fields ("all-field" error rate) and populated fields ("populated-field" error rate) as the denominators, to provide both an optimistic and a conservative measurement, respectively.

resultsOn average, the ACT NOW CE Study maintained an error rate between 1% (optimistic) and 3% (conservative). Additionally, we observed a decrease of 0.51 percentage points with each additional QC Event conducted.

conclusionsFormalized MRA training and continuous QC resulted in lower error rates than have been found in previous literature and a decrease in error rates over time. This study newly demonstrates the importance of continuous process controls for MRA within the context of a multi-site clinical research study.

Indexed as

Data AccuracyMedical RecordsData CollectionHumansInfant, NewbornResearch DesignRetrospective StudiesClinical data managementClinical researchData collectionData qualityMedical record abstraction

Identifiers

PMID35971057
PMCPMC9380367
OpenAlexW4291914979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.